Status
Conditions
Treatments
About
The aim of this study is to use artificial intelligence in the form of machine learning analysing vital signs as well as symptoms of patients suffering from Covid19 to identify predictors of disease progression and severe course of disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 2 patient groups
Loading...
Central trial contact
Annika Buchholz, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal